Pediatric endocrinology, diabetes, and metabolism
Efficacy of recombinant growth hormone therapy in children born small for gestational age (SGA): a retrospective analysis
Door Pałysa A, Kopiec-Burdecka M en Pyrżak B.
Inhoud in het Engels
Abstract
Introduction
Children born small for gestational age (SGA) present with a birth weight or length below -2 standard deviations (SD) relative to population norms for gestational age and sex. In Poland, such patients are eligible for recombinant human growth hormone (rhGH) therapy reimbursed by the National Health Fund.